Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Teva Pharmaceutical Industries Ltd (TEVA)

Teva Pharmaceutical Industries Ltd (TEVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Teva Pharmaceutical Industries Ltd 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 ISR

P: 972-3914-8171

Description:

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.

Key Statistics

Overview:

Market Capitalization, $K 12,057,778
Shares Outstanding, K 1,092,190
Annual Sales, $ 16,659 M
Annual Net Income, $ -3,990 M
Last Quarter Sales, $ 4,454 M
Last Quarter Net Income, $ 151,000 K
60-Month Beta 1.50
% of Insider Shareholders 0.56%
% of Institutional Shareholders 52.41%
Float, K 1,086,074
% Float 99.44%

Growth:

1-Year Return 4.16%
3-Year Return -39.62%
5-Year Return -81.14%
5-Year Revenue Growth -15.23%
5-Year Earnings Growth -54.80%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.68 on 02/10/21
Next Earnings Date 04/28/21
Earnings Per Share ttm 2.45
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 4.92%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.072 on 11/27/17
Next Ex-Dividends Date 11/27/17
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 07/01/04

TEVA Ratios

Ratio
Price/Earnings ttm 4.49
Price/Earnings forward 8.07
Price/Earnings to Growth 0.90
Return-on-Equity % 21.18%
Return-on-Assets % 5.13%
Profit Margin % -23.95
Net Margin % 18.62
Debt/Equity 2.06
Price/Sales 0.72
Price/Cash Flow 2.82
Price/Book 1.09
Book Value/Share 10.13
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar